G&E Herbal Biotechnology Statistics
Total Valuation
TPEX:4911 has a market cap or net worth of TWD 3.23 billion. The enterprise value is 2.82 billion.
Market Cap | 3.23B |
Enterprise Value | 2.82B |
Important Dates
The last earnings date was Friday, March 21, 2025.
Earnings Date | Mar 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:4911 has 59.00 million shares outstanding. The number of shares has increased by 0.06% in one year.
Current Share Class | n/a |
Shares Outstanding | 59.00M |
Shares Change (YoY) | +0.06% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 25.14% |
Owned by Institutions (%) | n/a |
Float | 44.17M |
Valuation Ratios
The trailing PE ratio is 31.62.
PE Ratio | 31.62 |
Forward PE | n/a |
PS Ratio | 12.96 |
PB Ratio | 3.87 |
P/TBV Ratio | 4.61 |
P/FCF Ratio | 25.07 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.69, with an EV/FCF ratio of 21.90.
EV / Earnings | 27.63 |
EV / Sales | 11.32 |
EV / EBITDA | 21.69 |
EV / EBIT | 23.57 |
EV / FCF | 21.90 |
Financial Position
The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.00.
Current Ratio | 3.61 |
Quick Ratio | 3.42 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.01 |
Debt / FCF | 0.01 |
Interest Coverage | 2,918.20 |
Financial Efficiency
Return on equity (ROE) is 12.78% and return on invested capital (ROIC) is 9.34%.
Return on Equity (ROE) | 12.78% |
Return on Assets (ROA) | 8.12% |
Return on Invested Capital (ROIC) | 9.34% |
Return on Capital Employed (ROCE) | 14.34% |
Revenue Per Employee | 6.39M |
Profits Per Employee | 2.62M |
Employee Count | 39 |
Asset Turnover | 0.27 |
Inventory Turnover | 1.96 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.05% in the last 52 weeks. The beta is -0.23, so TPEX:4911's price volatility has been lower than the market average.
Beta (5Y) | -0.23 |
52-Week Price Change | -3.05% |
50-Day Moving Average | 56.52 |
200-Day Moving Average | 56.16 |
Relative Strength Index (RSI) | 38.03 |
Average Volume (20 Days) | 30,462 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4911 had revenue of TWD 249.03 million and earned 102.06 million in profits. Earnings per share was 1.73.
Revenue | 249.03M |
Gross Profit | 205.34M |
Operating Income | 119.65M |
Pretax Income | 124.73M |
Net Income | 102.06M |
EBITDA | 129.24M |
EBIT | 119.65M |
Earnings Per Share (EPS) | 1.73 |
Balance Sheet
The company has 408.87 million in cash and 1.75 million in debt, giving a net cash position of 407.13 million or 6.90 per share.
Cash & Cash Equivalents | 408.87M |
Total Debt | 1.75M |
Net Cash | 407.13M |
Net Cash Per Share | 6.90 |
Equity (Book Value) | 833.53M |
Book Value Per Share | 14.13 |
Working Capital | 326.14M |
Cash Flow
In the last 12 months, operating cash flow was 134.68 million and capital expenditures -5.92 million, giving a free cash flow of 128.76 million.
Operating Cash Flow | 134.68M |
Capital Expenditures | -5.92M |
Free Cash Flow | 128.76M |
FCF Per Share | 2.18 |
Margins
Gross margin is 82.46%, with operating and profit margins of 48.04% and 40.98%.
Gross Margin | 82.46% |
Operating Margin | 48.04% |
Pretax Margin | 50.08% |
Profit Margin | 40.98% |
EBITDA Margin | 51.89% |
EBIT Margin | 48.04% |
FCF Margin | 51.70% |
Dividends & Yields
This stock pays an annual dividend of 0.76, which amounts to a dividend yield of 1.39%.
Dividend Per Share | 0.76 |
Dividend Yield | 1.39% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | 31.12% |
Buyback Yield | -0.06% |
Shareholder Yield | 1.33% |
Earnings Yield | 3.16% |
FCF Yield | 3.99% |
Stock Splits
The last stock split was on August 20, 2024. It was a forward split with a ratio of 1.06.
Last Split Date | Aug 20, 2024 |
Split Type | Forward |
Split Ratio | 1.06 |
Scores
TPEX:4911 has an Altman Z-Score of 16.84.
Altman Z-Score | 16.84 |
Piotroski F-Score | n/a |